Seagull Technologies has developed a novel cross-platform drug delivery method that
non-invasively delivers drugs ranging from small molecules to large proteins (with
or without nano-particle encapsulation) through biological tissues by an innovative
combination of nanotechnology and ultrasound.
removes the risks and discomfort associated with injections;
depending on the site of application, can be used for targeted or systemic drug delivery; and
may offer new opportunities for drugs that are inactivated by gastro-intestinal or liver metabolism; or cause untoward side effects from ingestion